Oct 15, 2024
Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial
Sep 30, 2024
Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
Sep 24, 2024
Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
Sep 03, 2024
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
Aug 26, 2024
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Jul 17, 2024
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Jul 15, 2024
Anixa Biosciences Announces $5 Million Share Repurchase Program
May 06, 2024
Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
Apr 18, 2024
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Mar 14, 2024
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Jan 29, 2024
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
Jan 23, 2024
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Feb 25, 2021
Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference
Jan 13, 2021
Anixa Biosciences to Present at the B. Riley Oncology Investor Conference
Jan 05, 2021
Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
Dec 14, 2020
Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing
Dec 01, 2020
Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology
Nov 23, 2020
Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine
Oct 27, 2020
Anixa Biosciences to Host Conference Call to Provide Update on Programs
Sep 08, 2020
Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference